The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Open accessAbstract
BACKGROUND & AIMS We estimated the accuracy of FibroScan vibration-controlled transient elastography controlled attenuation parameter (CAP) and liver stiffness measurement (LSMs) in assessing steatosis and fibrosis in patients with suspected nonalcoholic liver disease (NAFLD). METHODS We collected data from 450 consecutive adults who underwent liver biopsy analysis for suspected NAFLD at 7 centers in the United Kingdom from March 2014 through January 2017. FibroScan examinations with M or XL probe were completed within the 2 weeks of the biopsy analysis (404 had a valid examination). The biopsies were scored by 2 blinded expert pathologists according to nonalcoholic steatohepatitis clinical research network criteria. Diagnostic accuracy was estimated using the area under the receiver operating characteristic curves (AUROCs) for the categories of steatosis and fibrosis. We assessed effects of disease prevalence on positive and negative predictive values. For LSM, the effects of histological parameters and probe type were appraised using multivariable analysis. RESULTS Using biopsy analysis as the reference standard, we found that CAP identified patients with steatosis with an AUROC of 0.87 (95% confidence interval [CI] 0.82-0.92) for S≥S1, 0.77 (95% CI 0.71-0.82) for S≥S2, and 0.70 (95% CI 0.64-0.75) for S=S3. Youden cutoff values for S≥S1, S≥S2, and S≥S3 were 302 dB/m, 331 dB/m, and 337 dB/m, respectively. LSM identified patients with fibrosis with AUROCs of 0.77 (95% CI 0.72-0.82) for F≥F2, 0.80 (95% CI 0.75-0.84) for F≥F3, and 0.89 (95% CI 0.84-0.93) for F=F4. Youden cutoff values for F≥F2, F≥F3, and F=F4 were 8.2 kPa, 9.7 kPa, and 13.6 kPa, respectively. Applying the optimal cutoff values, determined from this cohort, to populations of lower fibrosis prevalence increased negative predictive values and reduced positive predictive values. Multivariable analysis found that the only parameter that significantly affected LSMs was fibrosis stage (P<10-16); we found no association with steatosis or probe type. CONCLUSIONS In a prospective analysis of patients with NAFLD, we found CAP and LSM by FibroScan to assess liver steatosis and fibrosis, respectively, with AUROC values ranging from 0.70 to 0.89. Probe type and steatosis did not affect LSM. STUDY REGISTRATION ClinicalTrials.gov Identifier: NCT01985009.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Correa, M. C., Montaner, J., S. Sulkowski, M., Torriani, F. J., Dieterich, D. T., Thomas, D. L., et al. (2006) · Hepatology · doi:10.1002/hep.21178 · Cited by 5,021
STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2015) · BMJ · doi:10.1136/bmj.h5527 · Cited by 3,660
Angulo, P., Hui, J. M., Marchesini, G., Bugianesi, E., George, J., Farrell, G. C., Enders, F., Saksena, S., Burt, A. D., Bida, J. P., et al. (2007) · Hepatology · doi:10.1002/hep.21496 · Cited by 3,203
Expanding consensus in portal hypertension
de Franchis, R. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.022 · Cited by 3,078
Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987
Transient elastography: a new noninvasive method for assessment of hepatic fibrosis
Sandrin, L., Fourquet, B., Hasquenoph, J.-M., Yon, S., Fournier, C., Mal, F., Christidis, C., Ziol, M., Poulet, B., Kazemi, F., et al. (2003) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2003.07.001 · Cited by 2,738
Dulai, P. S., Singh, S., Patel, J., Soni, M., Prokop, L. J., Younossi, Z., Sebastiani, G., Ekstedt, M., Hagstrom, H., Nasr, P., et al. (2017) · Hepatology · doi:10.1002/hep.29085 · Cited by 1,965
Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
Lee, J.-H., Kim, D., Kim, H. J., Lee, C.-H., Yang, J. I., Kim, W., Kim, Y. J., Yoon, J.-H., Cho, S.-H., Sung, M.-W., et al. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.08.002 · Cited by 1,621
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Younossi, Z. M., Blissett, D., Blissett, R., Henry, L., Stepanova, M., Younossi, Y., Racila, A., Hunt, S., & Beckerman, R. (2016) · Hepatology · doi:10.1002/hep.28785 · Cited by 1,285
Charlton, M. R., Burns, J. M., Pedersen, R. A., Watt, K. D., Heimbach, J. K., & Dierkhising, R. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.061 · Cited by 1,106
Bedossa, P., Poitou, C., Veyrie, N., Bouillot, J.-L., Basdevant, A., Paradis, V., Tordjman, J., & Clement, K. (2012) · Hepatology · doi:10.1002/hep.25889 · Cited by 903
Self-citationSasso, M., Beaugrand, M., de Ledinghen, V., Douvin, C., Marcellin, P., Poupon, R., Sandrin, L., & Miette, V. (2010) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2010.07.005 · Cited by 862
Self-citationTsochatzis, E. A., Gurusamy, K. S., Ntaoula, S., Cholongitas, E., Davidson, B. R., & Burroughs, A. K. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.033 · Cited by 709
Self-citationPark, C. C., Nguyen, P., Hernandez, C., Bettencourt, R., Ramirez, K., Fortney, L., Hooker, J., Sy, E., Savides, M. T., Alquiraish, M. H., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.026 · Cited by 708
Determination of reliability criteria for liver stiffness evaluation by transient elastography
Boursier, J., Zarski, J.-P., de Ledinghen, V., Rousselet, M.-C., Sturm, N., Lebail, B., Fouchard-Hubert, I., Gallois, Y., Oberti, F., Bertrais, S., et al. (2013) · Hepatology · doi:10.1002/hep.25993 · Cited by 662
Siddiqui, M. S., Vuppalanchi, R., Van Natta, M. L., Hallinan, E., Kowdley, K. V., Abdelmalek, M., Neuschwander-Tetri, B. A., Loomba, R., Dasarathy, S., Brandman, D., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.04.043 · Cited by 614
Guidelines on the management of abnormal liver blood tests
Newsome, P. N., Cramb, R., Davison, S. M., Dillon, J. F., Foulerton, M., Godfrey, E. M., Hall, R., Harrower, U., Hudson, M., Langford, A., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314924 · Cited by 535
Self-citationMyers, R. P., Pomier–Layrargues, G., Kirsch, R., Pollett, A., Duarte–Rojo, A., Wong, D., Beaton, M., Levstik, M., Crotty, P., & Elkashab, M. (2012) · Hepatology · doi:10.1002/hep.24624 · Cited by 503
Kwok, R., Choi, K. C., Wong, G. L.-H., Zhang, Y., Chan, H. L.-Y., Luk, A. O.-Y., Shu, S. S.-T., Chan, A. W.-H., Yeung, M.-W., Chan, J. C.-N., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309265 · Cited by 480
de Lédinghen, V., Vergniol, J., Capdepont, M., Chermak, F., Hiriart, J.-B., Cassinotto, C., Merrouche, W., Foucher, J., & Brigitte, L. B. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.018 · Cited by 379
Caussy, C., Alquiraish, M. H., Nguyen, P., Hernandez, C., Cepin, S., Fortney, L. E., Ajmera, V., Bettencourt, R., Collier, S., Hooker, J., et al. (2018) · Hepatology · doi:10.1002/hep.29639 · Cited by 375
de Lédinghen, V., Vergniol, J., Foucher, J., Merrouche, W., & le Bail, B. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02820.x · Cited by 367
Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease
Wong, V. W.-S., Vergniol, J., Wong, G. L.-H., Foucher, J., Chan, A. W.-H., Chermak, F., Choi, P. C.-L., Merrouche, W., Chu, S. H.-T., Pesque, S., et al. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.331 · Cited by 345
Myers, R. P., Pollett, A., Kirsch, R., Pomier‐Layrargues, G., Beaton, M., Levstik, M., Duarte‐Rojo, A., Wong, D., Crotty, P., & Elkashab, M. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02781.x · Cited by 343
Roulot, D., Costes, J.-L., Buyck, J.-F., Warzocha, U., Gambier, N., Czernichow, S., Le Clesiau, H., & Beaugrand, M. (2011) · Gut · doi:10.1136/gut.2010.221382 · Cited by 337
Transient elastography (FibroScan)
de Lédinghen, V., & Vergniol, J. (2008) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(08)73994-0 · Cited by 301
Vuppalanchi, R., Siddiqui, M. S., Van Natta, M. L., Hallinan, E., Brandman, D., Kowdley, K., Neuschwander‐Tetri, B. A., Loomba, R., Dasarathy, S., Abdelmalek, M., et al. (2018) · Hepatology · doi:10.1002/hep.29489 · Cited by 260
de Lédinghen, V., Wong, V. W.-S., Vergniol, J., Wong, G. L.-H., Foucher, J., Chu, S. H.-T., Le Bail, B., Choi, P. C.-L., Chermak, F., Yiu, K. K.-L., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.017 · Cited by 244
Petta, S., Maida, M., Macaluso, F. S., Di Marco, V., Cammà, C., Cabibi, D., & Craxì, A. (2015) · Hepatology · doi:10.1002/hep.27844 · Cited by 240
Petta, S., Wong, V. W., Cammà, C., Hiriart, J., Wong, G. L., Marra, F., Vergniol, J., Chan, A. W., Di Marco, V., Merrouche, W., et al. (2017) · Hepatology · doi:10.1002/hep.28843 · Cited by 214
Harris, R., Harman, D. J., Card, T. R., Aithal, G. P., & Guha, I. N. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30205-9 · Cited by 197
Self-citationTapper, E. B., Challies, T., Nasser, I., Afdhal, N. H., & Lai, M. (2016) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.49 · Cited by 164
Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter
Wong, V. W., Petta, S., Hiriart, J., Cammà, C., Wong, G. L., Marra, F., Vergniol, J., Chan, A. W. H., Tuttolomondo, A., Merrouche, W., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.005 · Cited by 147
Sasso, M., Audière, S., Kemgang, A., Gaouar, F., Corpechot, C., Chazouillères, O., Fournier, C., Golsztejn, O., Prince, S., Menu, Y., et al. (2015) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2015.08.008 · Cited by 144
Self-citationGarg, H., Aggarwal, S., Shalimar, S., Yadav, R., Gupta, S. D., Agarwal, L., & Agarwal, S. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.09.005 · Cited by 112
Runge, J. H., Smits, L. P., Verheij, J., Depla, A. C. T. M., Kuiken, S. D., Baak, B. C., Nederveen, A. J., Beuers, U. H., & Stoker, J. (2017) · Radiology · doi:10.1148/radiol.2017162931 · Cited by 110
de Lédinghen, V., Hiriart, J., Vergniol, J., Merrouche, W., Bédossa, P., & Paradis, V. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4638-3 · Cited by 95
Self-citationChan, W., Mustapha, N. R. N., Wong, G. L., Wong, V. W., & Mahadeva, S. (2016) · United European Gastroenterology Journal · doi:10.1177/2050640616646528 · Cited by 80
A prospective comparative assessment of the accuracy of the FibroScan in evaluating liver steatosis
Jun, B. G., Park, W. Y., Park, E. J., Jang, J. Y., Jeong, S. W., Lee, S. H., Kim, S. G., Cha, S., Kim, Y. S., Cho, Y. D., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182784 · Cited by 49
Naveau, S., Voican, C. S., Lebrun, A., Gaillard, M., Lamouri, K., Njiké‐Nakseu, M., Courie, R., Tranchart, H., Balian, A., Prevot, S., et al. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000919 · Cited by 37
Cited by
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Self-citationA multisociety Delphi consensus statement on new fatty liver disease nomenclature
Rinella, M. E., Lazarus, J. V., Ratziu, V., Francque, S. M., Sanyal, A. J., Kanwal, F., Romero, D., Abdelmalek, M. F., Anstee, Q. M., Arab, J. P., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000520 · Cited by 3,476
“Such cases and also cryptogenic cases that subsequently manifest CMRF can be rebadged as MASLD.”
Self-citationA multisociety Delphi consensus statement on new fatty liver disease nomenclature
Rinella, M. E., Lazarus, J. V., Ratziu, V., Francque, S. M., Sanyal, A. J., Kanwal, F., Romero, D., Abdelmalek, M. F., Anstee, Q. M., Arab, J. P., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.06.003 · Cited by 3,100
Self-citationNon-alcoholic fatty liver disease
Powell, E. E., Wong, V. W.-S., & Rinella, M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32511-3 · Cited by 2,789
Berzigotti, A., Tsochatzis, E., Boursier, J., Castera, L., Cazzagon, N., Friedrich-Rust, M., Petta, S., & Thiele, M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.05.025 · Cited by 1,925
“Cut-off values of 263 dB/m [119] and 274 dB/m [118] had high sensitivities and positive predictive values (>90%) for detecting”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Eddowes, P. J., Sasso, M., Allison, M., Tsochatzis, E., Anstee, Q. M., Sheridan, D., Guha, I. N., Cobbold, J. F., Deeks, J. J., Paradis, V., Bedossa, P., & Newsome, P. N.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 156
- Issue
- 6
- Pages
- 1717-1730
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2908524400
- Cited by
- 1,410
- References
- 43
- FWCI
- 90.42
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- Birmingham Biomedical Research Centre
- NIHR Bristol Biomedical Research Centre (BRC-1215-20009)
- National Institute for Health Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.